Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Geriatric Medicine
•
Dementia
What is your approach to the management of transfusion reactions with lecanemab, both in the immediate setting and with respect to the prevention of reactions with future infusions?
Related Questions
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
How do you treat agitation in progressive supranuclear palsy?
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
How do you choose among SSRIs and dosing strategies for the management of behavioral and psychological symptoms of dementia?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
What are the limits and standalone value of volumetric MRI for the preclinical evaluation of dementia?
How do you select between antipsychotics in the treatment of delirium refractory to nonpharmacological management in hospitalized older adults with dementia?
How do you approach balancing the treatment of urinary incontinence with anticholinergic medications with the use of cholinesterase inhibitors in dementia?
What is your approach to deprescribing cholinesterase inhibitors and/or memantine in advancing stages of dementia?
How do you approach individualizing A1c goals in patients with dementia?
